P-1137. Molecular and Culture-Based Surveillance of Environmental Clostridioides difficile Contamination

Abstract Background Environmental contamination by Clostridioides difficile poses a significant challenge in healthcare settings. Molecular detection was performed using a C. difficile-specific16S rRNA primer alongside the tcdB toxin gene target. We compared molecular detection (16S and tcdB gene qPCR) and culture positivity.Table 1.Molecular and Culture Positivity by Sample Area and Patient Infection StatusFluorescent Marker Presence by Sample Area and Patient Infection Status Methods We conducted a prospective study to measure environmental contamination using molecular and culture-based detection methods, grouping by infection status. All enrolled patients (N=10) were C. difficile PCR-positive; 5 were toxin-positive (defined as infected), and 5 were toxin-negative (defined as colonized). Samples were tested for C. difficile 16S rRNA and tcdB via qPCR and cultured on selective media. A sample was considered qPCR-positive if both targets were detected. Additionally, fluorescent markers were applied to predefined high-touch surfaces in each patient room to assess environmental cleaning. Results A total of 132 environmental samples were collected in 10 patient rooms from 7 predefined zones: patient area (bedrails, overbed table, footboard), bathroom area (toilet seat, bathroom sink, floor around the toilet), floor area (between the patient bed and bathroom), care area (computer keyboard, mouse, IV pole), socks, mobile equipment, and healthcare providers’ PPE (isolation gown and gloves). Of 116 samples tested by qPCR, 20 (17%) were positive for both 16S and tcdB from environments of infected patients, and 7 (6%) from colonized patients (p=0.021) (Table 1). Of 132 samples, 10 (8%) were recovered via culture C. difficile from infected patients and 4 (3%) from colonized patients (p=0.015). The highest positivity rates were observed in patient areas, bathrooms, and floors, with minimal detection observed on HCP PPE and mobile equipment. Fluorescent markers were observed in rooms of infected (92%) and colonized patients (78%), suggesting no substantial difference in environmental cleaning between groups (Table 2). Conclusion In this cohort of PCR-positive patients, molecular detection consistently identified more environmental contamination than culture, with the greatest burden in environments of infection. Similarly, culture positivity was significantly higher in environments of infected patients compared to colonized patients. Disclosures Nicholas A. Turner, MD, MHSc, PDI: Grant/Research Support|Purio Labs: Grant/Research Support

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.1331
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1137. Molecular and Culture-Based Surveillance of Environmental Clostridioides difficile Contamination

Anderson Dm, Bobby Warren, Nicholas Turner, Guerbine Fils-Aime et al.
Open Forum Infectious Diseases
Clostridium difficile and Clostridium perfringens research
article

P-1137. Molecular and Culture-Based Surveillance of Environmental Clostridioides difficile Contamination

Anderson Dm, Bobby Warren, Nicholas Turner, Guerbine Fils-Aime, Aaron Barrett, Amanda M Graves
article en

Abstract

Abstract Background Environmental contamination by Clostridioides difficile poses a significant challenge in healthcare settings. Molecular detection was performed using a C. difficile-specific16S rRNA primer alongside the tcdB toxin gene target. We compared molecular detection (16S and tcdB gene qPCR) and culture positivity.Table 1.Molecular and Culture Positivity by Sample Area and Patient Infection StatusFluorescent Marker Presence by Sample Area and Patient Infection Status Methods We conducted a prospective study to measure environmental contamination using molecular and culture-based detection methods, grouping by infection status. All enrolled patients (N=10) were C. difficile PCR-positive; 5 were toxin-positive (defined as infected), and 5 were toxin-negative (defined as colonized). Samples were tested for C. difficile 16S rRNA and tcdB via qPCR and cultured on selective media. A sample was considered qPCR-positive if both targets were detected. Additionally, fluorescent markers were applied to predefined high-touch surfaces in each patient room to assess environmental cleaning. Results A total of 132 environmental samples were collected in 10 patient rooms from 7 predefined zones: patient area (bedrails, overbed table, footboard), bathroom area (toilet seat, bathroom sink, floor around the toilet), floor area (between the patient bed and bathroom), care area (computer keyboard, mouse, IV pole), socks, mobile equipment, and healthcare providers’ PPE (isolation gown and gloves). Of 116 samples tested by qPCR, 20 (17%) were positive for both 16S and tcdB from environments of infected patients, and 7 (6%) from colonized patients (p=0.021) (Table 1). Of 132 samples, 10 (8%) were recovered via culture C. difficile from infected patients and 4 (3%) from colonized patients (p=0.015). The highest positivity rates were observed in patient areas, bathrooms, and floors, with minimal detection observed on HCP PPE and mobile equipment. Fluorescent markers were observed in rooms of infected (92%) and colonized patients (78%), suggesting no substantial difference in environmental cleaning between groups (Table 2). Conclusion In this cohort of PCR-positive patients, molecular detection consistently identified more environmental contamination than culture, with the greatest burden in environments of infection. Similarly, culture positivity was significantly higher in environments of infected patients compared to colonized patients. Disclosures Nicholas A. Turner, MD, MHSc, PDI: Grant/Research Support|Purio Labs: Grant/Research Support

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Duke University (US), Duke Medical Center (US)
Openalex Percentile: Top 92%
Clostridium difficile and Clostridium perfringens research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.